Growth Hormone Deficiency Market Analysis

  • Report ID: 2683
  • Published Date: Oct 16, 2024
  • Report Format: PDF, PPT

Growth Hormone Deficiency Market Analysis

The growth hormone deficiency market is segmented by application, route of administration, distribution channel, and region. Among product applications, the Turner syndrome segment is expected to dominate the market on account of a surge in its incidence across the globe and better awareness of Turner syndrome in the medical community. Turner syndrome is a chromosomal abnormality in females, characterized by the partial or complete loss of one of the X chromosomes. As the syndrome is associated with many complications related to heart, hearing loss, autoimmune disorders, mental health issues, infertility, and pregnancy complications, the demand for treatment concerning growth hormones is growing.

Non-profit establishments such as Turner Syndrome Support Society (U.K.), Turner Syndrome Society of the United States, and Turner Syndrome Foundation celebrate “Turner Syndrome Awareness Month” every year and spread awareness about the condition via nationwide campaigns which were affected this year owing to COVID-19.

Our in-depth analysis of the global market includes the following segments:

 

           By Application

  • Growth Hormone (GH) Deficiency
    • Adult GH Deficiency
    • Pediatric GH Deficiency
  • Turner Syndrome
  • Idiopathic Short Stature
  • Prader-Willi Syndrome
  • Small for Gestational Age
  • Other

             By Route Of Administration

  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Oral

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Clinics
  • E-Commerce Websites
 

 

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 2683
  • Published Date: Oct 16, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of growth hormone deficiency is assessed at USD 4.64 billion.

Growth Hormone Deficiency Market size was valued at USD 4.51 billion in 2023 and is expected to reach USD 7.23 billion by 2036, registering around 3.7% CAGR during the forecast period i.e., between 2024-2036.

North America industry is expected to hold largest revenue share by 2036, attributed to factors such as high healthcare expenditure, and amplified intake of human growth hormone therapies in the region in order to cure different syndromes such as Turner syndrome.

The major players in the market are Merck KGaA, Teva Pharmaceuticals Industries Ltd., Ipsen Pharma Biotech SAS, Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche Ltd, Ferring B.V., Novo Nordisk A/S, Eli Lilly and Company, AnkeBio Co., Ltd, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample